IL2RB and neoplasm: Galectin-1 can influence the proliferation of CD8†T cells and the immunosuppressive capacity of CD8†CD122†PD-1†Tregs, lower Galectin-1 expression result in reduced tumor growth (Cagnoni et al., 2021).